Martin Meglasson
2007 - Ligand Pharmaceuticals
In 2007, Martin Meglasson earned a total compensation of $556.1K as Vice President, Discovery Research at Ligand Pharmaceuticals, a 19% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $142,861 |
---|---|
Option Awards | $92,368 |
Salary | $300,760 |
Stock Awards | $12,757 |
Other | $7,322 |
Total | $556,067 |
Meglasson received $300.8K in salary, accounting for 54% of the total pay in 2007.
Meglasson also received $142.9K in non-equity incentive plan, $92.4K in option awards, $12.8K in stock awards and $7.3K in other compensation.
Rankings
In 2007, Martin Meglasson's compensation ranked 5,726th out of 8,700 executives tracked by ExecPay. In other words, Meglasson earned more than 34.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,726 out of 8,700 | 34th |
Division Manufacturing | 2,150 out of 3,314 | 35th |
Major group Chemicals And Allied Products | 465 out of 746 | 38th |
Industry group Drugs | 315 out of 546 | 42nd |
Industry Pharmaceutical Preparations | 230 out of 364 | 37th |
Source: SEC filing on April 29, 2009.
Meglasson's colleagues
We found four more compensation records of executives who worked with Martin Meglasson at Ligand Pharmaceuticals in 2007.